title: Childhood subepidermal blistering disease with autoantibodies to type VII collagen and laminin-332.
authors.forename: H-Y
authors.initials: HY
authors.lastname: Lin
authors.forename: T
authors.initials: T
authors.lastname: Yanagi
authors.forename: M
authors.initials: M
authors.lastname: Akiyama
authors.forename: M M
authors.initials: MM
authors.lastname: Iitani
authors.forename: R
authors.initials: R
authors.lastname: Moriuchi
authors.forename: K
authors.initials: K
authors.lastname: Natsuga
authors.forename: S
authors.initials: S
authors.lastname: Shinkuma
authors.forename: N
authors.initials: N
authors.lastname: Yamane
authors.forename: D
authors.initials: D
authors.lastname: Inokuma
authors.forename: K
authors.initials: K
authors.lastname: Arita
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D001768:Blister / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D002990:Clobetasol / Q000627:therapeutic use; D024143:Collagen Type VII / Q000276:immunology*; D005260:Female; D006801:Humans; D007797:Laminin / Q000276:immunology*; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D024143:Collagen Type VII; D007797:Laminin; D002990:Clobetasol